Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a refreshed version of the study record content.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:22.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', indicating enrollment for the study has ended. Additional edits add new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjust the Intervention/Treatment labeling and a site revision note, reflecting formatting and navigational updates.
    Difference
    0.4%
    Check dated 2026-06-15T20:00:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.5 has been added to the page, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T16:54:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page’s revision label has been updated from v3.5.3 to v3.5.4, indicating a maintenance update; the study content and structure remain the same.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:05.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:32:24.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:57:29.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.